UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$129,790,000
-68.2%
180,7900.0%0.00%
Q4 2021$408,585,000
-18.5%
180,790
+3.8%
0.00%
Q3 2021$501,619,000
-33.4%
174,173
-12.4%
0.00%
Q2 2021$753,224,000
+138.2%
198,740
+112.7%
0.00%
Q1 2021$316,220,000
+28.2%
93,418
+6.1%
0.00%
Q4 2020$246,624,000
+11.6%
88,0800.0%0.00%
Q3 2020$221,081,000
-81.7%
88,080
-1.2%
0.00%
-100.0%
Q2 2020$1,211,160,000
+101.9%
89,187
+12.7%
0.00%
Q1 2020$599,797,000
+13.7%
79,129
-5.2%
0.00%
Q4 2019$527,588,000
+67.6%
83,479
+3.9%
0.00%
Q3 2019$314,811,000
-13.1%
80,309
+7.3%
0.00%
Q2 2019$362,182,000
-30.4%
74,831
+17.8%
0.00%
Q1 2019$520,212,000
+131.1%
63,518
+56.0%
0.00%
Q4 2018$225,137,000
+43.2%
40,712
+128.7%
0.00%
Q3 2018$157,174,000
-11.5%
17,8000.0%0.00%
Q2 2018$177,644,000
+4.7%
17,8000.0%0.00%
Q1 2018$169,634,00017,8000.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,121,283$53,979,0004.02%
DAFNA Capital Management LLC 853,538$6,470,0002.70%
Baupost Group 17,527,968$132,862,0001.96%
Nantahala Capital Management 6,559,478$49,721,0001.86%
Novo Holdings A/S 3,393,039$25,719,0001.72%
Abrams Capital Management 5,656,462$42,876,0001.69%
Stanley-Laman Group, Ltd. 319,073$2,419,0000.73%
Integral Health Asset Management, LLC 200,000$1,516,0000.67%
KNOTT DAVID M 135,169$1,025,0000.65%
Leap Investments LP 54,700$415,0000.61%
View complete list of AKEBIA THERAPEUTICS INC shareholders